MacroGenics, Inc.
MGNX
$1.77
$0.0855.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 66.53% | 220.78% | -196.86% | -37.31% | -459.88% |
| Total Depreciation and Amortization | 8.05% | -5.90% | -35.60% | -38.28% | -41.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -909.72% | 113.32% | 106.64% | -18.65% | -55.88% |
| Change in Net Operating Assets | -79.33% | 52.91% | -90.87% | -100.92% | 129.48% |
| Cash from Operations | -36.99% | 270.69% | -2,029.49% | -255.67% | -195.62% |
| Capital Expenditure | 0.00% | -18.64% | -261.89% | -306.41% | -57.76% |
| Sale of Property, Plant, and Equipment | -- | 700.00% | 48.15% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.71% | 209.31% | 142.73% | -7.74% | 831.08% |
| Cash from Investing | 6.81% | 206.19% | 141.80% | -11.75% | 770.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.97% | -88.46% | 184.23% | 324.96% | -79.84% |
| Repurchase of Common Stock | -- | 47.52% | 14.29% | -1,413.29% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.22% | -100.14% | 959.32% | -99.75% | -79.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.93% | 607.39% | 103.10% | -117.85% | -55.57% |